Trial Profile
Phase II Trial of Epirubicin Cisplatin and FU Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2012
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Cisplatin; Epirubicin; Fluorouracil
- Indications Gastric cancer
- Focus Therapeutic Use
- 27 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Aug 2010 Planned end date changed from 1 Dec 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov.
- 27 May 2009 New trial record